Home
About us
- Team
- Board
- CAB
- Investors
Our Science
- ISM-001
News & Events
- News
- Events
Contact us

Connect with us

© Copyright 2024 Isomab

Author: pconington

IsomAb Announces Strategic Collaboration with Catalent

Posted on October 29, 2024November 4, 2024 by pconington

Posted in Uncategorized

Search

Recent Posts

IsomAb Announces Strategic Collaboration with Catalent
IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer
IsomAb Announces the Expansion of its Clinical Advisory Board
IsomAb Appoints Dr Anker Lundemose as a Non-Executive Director
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease

Recent Comments

No comments to show.

Archives

October 2024
July 2024
April 2024
February 2024

Categories

Uncategorized

Terms of use

Privacy Policy & Cookies

© Copyright 2024 Isomab

Connect with us